Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease

Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials